Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Other Working Capital Changes (2021 - 2025)

Cingulate's (CINGW) quarterly Other Working Capital Changes came in at -$248697.0 in Q4 2025, up 75.55% on a YoY basis from -$141668.9 in Q4 2024, and down 3287.78% quarter-over-quarter from -$7341.0 in Q3 2025.

Analysis

Cingulate (CINGW) Other Working Capital Changes (2021 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Other Working Capital Changes for 5 consecutive years, with -$248697.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 75.55% year-over-year to -$248697.0; the trailing twelve-month figure through Dec 2025 stood at $623705.0 (up 374.25% YoY), and the FY2025 full-year result was $623705.0, up 374.25% from the prior year.
  • Other Working Capital Changes declined to -$248697.0 in Q4 2025 per CINGW's latest filing, from -$7341.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.7 million in Q3 2021 and bottomed at -$1.6 million in Q4 2021.
  • Historically, Other Working Capital Changes has averaged $23417.0 across 5 years, with a median of $89976.5 in 2021.
  • The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes tumbled 308.88% in 2022, then soared 471.04% in 2024.
  • Over 5 years, Other Working Capital Changes stood at -$1.6 million in 2021, then jumped by 118.13% to $287451.0 in 2022, then plunged by 238.71% to -$398730.0 in 2023, then plunged by 155.08% to -$1.0 million in 2024, then surged by 75.55% to -$248697.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$248697.0, -$7341.0, and $358467.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn
10 Cingulate 100,214.03 100,214.03 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -248,697.00
Dec 31, 2025 -248,697.00
Sep 30, 2025 -7,341.00
Sep 30, 2025 -7,341.00
Jun 30, 2025 358,467.00
Jun 30, 2025 358,467.00
Mar 31, 2025 521,276.00
Mar 31, 2025 521,276.00
Dec 31, 2024 -1.02 Mn
Dec 31, 2024 -1.02 Mn
Sep 30, 2024 830,401.00
Sep 30, 2024 830,401.00
Jun 30, 2024 -1.14 Mn
Jun 30, 2024 -1.14 Mn
Mar 31, 2024 1.10 Mn
Mar 31, 2024 1.10 Mn
Dec 31, 2023 -398,730.00
Dec 31, 2023 -398,730.00
Sep 30, 2023 -742,270.00
Sep 30, 2023 -742,270.00